Sahajanand Medical Technologies IPO Day 2: Latest GMP, Subscription Status, and Essential Insights Revealed!

Sahajanand Medical Technologies has launched its initial public offering (IPO), which is currently in the second day of bidding as of October 16, 2026. The company aims to raise Rs 475.48 crore through this offering, which consists entirely of an offer for sale (OFS) of 1.38 crore shares. The IPO price band has been set between Rs 327 and Rs 344 per share, with a lot size of 43 shares, making the minimum investment for retail investors at Rs 14,792 at the upper price point. The IPO will remain open for subscription until October 19, 2026, and shares are tentatively scheduled to list on the BSE and NSE on October 23, 2026.

As of Day 1 of the bidding, the IPO was subscribed 34% overall, with the retail individual investor (RII) category seeing a subscription rate of 40% against 47.50 lakh allocated shares. Interestingly, the grey market premium (GMP) sits at Rs 41 per share, translating to approximately 12% above the upper end of the price band. This level of GMP indicates potential optimism about listing gains, although it is important to note that GMP is not an official metric and does not guarantee actual performance on listing day.

This IPO could be a significant opportunity for retail investors given the promising financial performance of Sahajanand Medical Technologies, which reported an 18% increase in total income and a remarkable 175% surge in profit after tax for FY26. The heightened GMP suggests bullish sentiment in the grey market, which may encourage retail investors to participate actively. However, investors should remain cautious, considering the inherent risks associated with the market and the fluctuating nature of GMP.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)